Subclones dominate at MDS progression following allogeneic hematopoietic cell transplant

Allogeneic hematopoietic cell transplantation (alloHCT) is a potentially curative treatment for myelodysplastic syndromes (MDS), but patients who relapse after transplant have poor outcomes. In order to understand the contribution of tumor clonal evolution to disease progression,we applied exome and...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:JCI Insight
Egile Nagusiak: Jacoby, Meagan A., Duncavage, Eric J., Chang, Gue Su, Miller, Christopher A., Shao, Jin, Elliott, Kevin, Robinson, Joshua, Fulton, Robert S., Fronick, Catrina C., O’Laughlin, Michelle, Heath, Sharon E., Pusic, Iskra, Welch, John S., Link, Daniel C., DiPersio, John F., Westervelt, Peter, Ley, Timothy J., Graubert, Timothy A., Walter, Matthew J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Clinical Investigation 2018
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5922277/
https://ncbi.nlm.nih.gov/pubmed/29515031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.98962
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak